Michael D. West
2008 - BioTime
In 2008, Michael D. West earned a total compensation of $274.5K as Chief Executive Officer at BioTime, a 280% increase compared to previous year.
Compensation breakdown
| Salary | $250,000 |
|---|---|
| Other | $24,500 |
| Total | $274,500 |
West received $250K in salary, accounting for 91% of the total pay in 2008.
West also received $24.5K in other compensation.
Rankings
In 2008, Michael D. West's compensation ranked 8,070th out of 9,135 executives tracked by ExecPay. In other words, West earned more than 11.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,070 out of 9,135 | 12th |
Division Manufacturing | 3,063 out of 3,436 | 11th |
Major group Chemicals And Allied Products | 723 out of 815 | 11th |
Industry group Drugs | 527 out of 597 | 12th |
Industry Biological Products, Except Diagnostic Substances | 100 out of 118 | 15th |
Source: SEC filing on September 16, 2009.
West's colleagues
We found one more compensation record of an executive who worked with Michael D. West at BioTime in 2008.
2008
Robert Peabody
BioTime
Chief Operating Officer
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019